chevron_leftBack
As of 8 June 2026, BIFIDO Co., Ltd. has a market cap of $15.16M USD, ranking #38926 globally and #2472 in South Korea.
It ranks #3478 in the Healthcare sector, and #227 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$15.16MUSD
23.23B KRW
Enterprise Value
$17.83MUSD
27.82B KRW
Revenue (TTM)
$12.84MUSD
19.68B KRW
EBITDA (TTM)
$2.45MUSD
3.82B KRW
Net Income (TTM)
-$125.74KUSD
-192.74M KRW
EBITDA Margin
19%
Profit Margin
-1%
PS Ratio
1.2
PB Ratio
0.5
EV/EBITDA
7.3
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.4% | -3.6% | -2.4% | -5.5% | -27% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
238200
주식회사 비피도 Ordinary Shares
ISIN: KR7238200000
Shares Out.:
Shares Outstanding:
8.18M1
Shares Float:
5.636M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2,870 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BIFIDO Co., Ltd.
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 317450
|
$539.11M
3K%
826.36B KRW
|
8.4
|
|
KRX: 220100
|
$278.08M
2K%
426.25B KRW
|
-
|
|
KRX: 200130
|
$218.56M
1K%
335.01B KRW
|
-
|
|
KRX: 009290
|
$203.29M
1K%
311.61B KRW
|
16.3
|
|
KRX: 194700
|
$167.22M
1K%
256.31B KRW
|
7.4
|
|
KRX: 011040
|
$98.78M
552%
151.41B KRW
|
17.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
248K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
195K%
|
-
|
|
SHE: 002001
|
$15.86B
105K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.12B
73K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
72K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
60K%
61.6B CNY
|
80.6
|
chevron_leftBack